
<div class="section-1">
      <ul id="menu">
         <li id="nav-1"><a href="index.html">Synopsis</a></li>
         <li id="nav-2"><a href="mrsab.html">MRSAB.RRF</a></li>
         <li id="nav-3"><a href="sourcemetastats.html">Statistics and Sample Data</a>
 
         <ul id="subnav-3">
               <li><a href="termtypes.html">Terms and term types</a></li>
               <li><a href="attributes.html">Attributes</a></li>
               <li><a href="relationships.html">Relationships</a></li>
               <li><a href="semtypes.html">Semantic Types</a></li>
               <li><a href="overlap.html">Source Overlap</a></li>
 
         </ul>
         </li>
     <!--  <li id="nav-4"> <a href="representation.html">Representation</a>
       <ul id="subnav-4">
         <li> <a href="sourcerepresentation.html">Source
   Representation</a> </li>
         <li> <a href="metarepresentation.html">Metathesaurus
   Representation</a> </li>
       </ul>
     </li> -->
    </ul>
  </div>
  <div id = "summary">
  
  
  <p><b>Authority</b><br/>
  The National Drug File - Reference Terminology (NDF-RT) is produced by the U.S. Department of Veterans Affairs, Veterans Health Administration (VHA).
  </p>
 
  
  
  <p><b>Purpose</b><br/>
  NDF-RT is an extension of the VHA National Drug File (NDF).  It organizes the drug list into a formal representation.
  <br /><br />
  NDF-RT is used for modeling drug characteristics including ingredients, chemical structure, dose form, physiologic effect, mechanism of action, pharmacokinetics, and related diseases.
  </p>
  
  <p><b>Description</b><br/>
  NDF-RT combines the NDF hierarchical drug classification with a multi-category reference model.
  The categories are: </p>
  <ol>
  	<li>Cellular or Molecular Interactions [MoA]</li>
    <li>Chemical Ingredients [Chemical/Ingredient]</li>
    <li>Clinical Kinetics [PK]</li>
    <li>Diseases, Manifestations or Physiologic States [Disease/Finding]</li>
    <li>Dose Forms [Dose Form]</li>
    <li>Pharmaceutical Preparations</li>
    <li>Physiological Effects [PE]</li>
    <li>Therapeutic Categories [TC]</li>
    <li>VA Drug Interactions [VA Drug Interaction]</li>
  </ol>
  <p>For more information about NDF in the Metathesaurus, see the <a href="../VANDF/index.html">NDF source synopsis</a>.
  </p>
 
  
  <p><b>Update Frequency</b><br/>
  NDF-RT is updated monthly.
  </p>
  
  <p><b>Metathesaurus Update Frequency</b><br/>
  NDF-RT is updated in each Metathesaurus release as part of <a href="../RXNORM/index.html">RxNorm</a>..</p>
  
  
  
  <p><b>Sites Consulted</b></p>
 
  
  <ol>
  <li>Carter JS, Brown SH, Bauer BA, Elkin PL, Erlbaum MS, Froehling DA, Lincoln MJ, Rosenbloom ST, Wahner-Roedler DL, Tuttle MS. Categorical information in pharmaceutical terminologies. AMIA Annu Symp Proc. 2006:116-20. Cited in: PubMed; PMID 17238314. Available from: <a href = "http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1839555" target = "_blank">http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1839555</a></li>
  <li>Chute CG, Carter JS, Tuttle MS, Haber M, Brown SH. Integrating pharmacokinetics knowledge into a drug ontology: as an extension to support pharmacogenomics. AMIA Annu Symp Proc. 2003:170-4. Cited in PubMed; PMID: 14728156. About the HGNC; [updated 2007 Feb 16; cited 2008 Sep 17]. Available from: <a href = "http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1480302/?tool=pmcentrez" target = "_blank">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1480302/?tool=pmcentrez</a> </li>
  </ol>
  
  
  
  
  </div>
 

